Michael J. Madson, Unnati Srivastava, Yoshita Gade
{"title":"Recommendations From Arizona Budtenders to Mystery Callers Regarding Morning Sickness","authors":"Michael J. Madson, Unnati Srivastava, Yoshita Gade","doi":"10.1016/j.jogn.2025.02.001","DOIUrl":null,"url":null,"abstract":"<div><h3>Objective</h3><div>To explore the recommendations for managing morning sickness made by Arizona budtenders, including types of products suggested and frequency of referrals to medical professionals.</div></div><div><h3>Design</h3><div>Descriptive observational study using mystery calling.</div></div><div><h3>Setting</h3><div>Eligible dispensaries in 12 of Arizona’s 15 counties.</div></div><div><h3>Participants</h3><div>Budtenders (<em>N</em> = 104) who answered the phone during regular business hours.</div></div><div><h3>Methods</h3><div>Two researchers mystery called eligible dispensaries between February and April 2024 and documented budtender responses on a standardized form. We used counts, percentages, and 95% confidence intervals to analyze the data.</div></div><div><h3>Results</h3><div>The response rate was 67%. Most budtenders (71.2%, <em>n</em> = 74) recommended cannabis products for morning sickness, especially cannabidiol and edibles. One fifth of these budtenders (18.9%, <em>n</em> = 14) recommended tinctures, one eighth (12.2%, <em>n</em> = 9) recommended inhalation products such as vapes and joints, and a few (5.4%, <em>n =</em> 4) recommended topicals. Most budtenders (85.6%, <em>n</em> = 89) encouraged a medical consultation, but relatively few (34.6%, <em>n</em> = 36) did so without prompting.</div></div><div><h3>Conclusion</h3><div>Future researchers should investigate whether these trends are similar in other regions where cannabis is legal. Obstetrics and gynecology nurses should counsel patients proactively about prenatal cannabis use. Policymakers should consider mandating budtender training on cannabis risks during pregnancy as well as pregnancy-specific product warnings.</div></div>","PeriodicalId":54903,"journal":{"name":"Jognn-Journal of Obstetric Gynecologic and Neonatal Nursing","volume":"54 3","pages":"Pages 282-287.e1"},"PeriodicalIF":2.0000,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Jognn-Journal of Obstetric Gynecologic and Neonatal Nursing","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0884217525000103","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/2/28 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"NURSING","Score":null,"Total":0}
引用次数: 0
Abstract
Objective
To explore the recommendations for managing morning sickness made by Arizona budtenders, including types of products suggested and frequency of referrals to medical professionals.
Design
Descriptive observational study using mystery calling.
Setting
Eligible dispensaries in 12 of Arizona’s 15 counties.
Participants
Budtenders (N = 104) who answered the phone during regular business hours.
Methods
Two researchers mystery called eligible dispensaries between February and April 2024 and documented budtender responses on a standardized form. We used counts, percentages, and 95% confidence intervals to analyze the data.
Results
The response rate was 67%. Most budtenders (71.2%, n = 74) recommended cannabis products for morning sickness, especially cannabidiol and edibles. One fifth of these budtenders (18.9%, n = 14) recommended tinctures, one eighth (12.2%, n = 9) recommended inhalation products such as vapes and joints, and a few (5.4%, n = 4) recommended topicals. Most budtenders (85.6%, n = 89) encouraged a medical consultation, but relatively few (34.6%, n = 36) did so without prompting.
Conclusion
Future researchers should investigate whether these trends are similar in other regions where cannabis is legal. Obstetrics and gynecology nurses should counsel patients proactively about prenatal cannabis use. Policymakers should consider mandating budtender training on cannabis risks during pregnancy as well as pregnancy-specific product warnings.
期刊介绍：
JOGNN is a premier resource for health care professionals committed to clinical scholarship that advances the health care of women and newborns. With a focus on nursing practice, JOGNN addresses the latest research, practice issues, policies, opinions, and trends in the care of women, childbearing families, and newborns.
This peer-reviewed scientific and technical journal is highly respected for groundbreaking articles on important - and sometimes controversial - issues. Articles published in JOGNN emphasize research evidence and clinical practice, building both science and clinical applications. JOGNN seeks clinical, policy and research manuscripts on the evidence supporting current best practice as well as developing or emerging practice trends. A balance of quantitative and qualitative research with an emphasis on biobehavioral outcome studies and intervention trials is desired. Manuscripts are welcomed on all subjects focused on the care of women, childbearing families, and newborns.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
